Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Promoting Equity in Transplant Research by Addressing the Exclusion of Patients With Glomerular Disease.
Journal: Kidney international reports
Published: September 22, 2025
Spatial transcriptomics reveals distinct role of monocytes/macrophages with high FCGR3A expression in kidney transplant rejections.
Journal: Frontiers in immunology
Published: June 26, 2025
Efficacy and Safety of Once-Daily LCP-Tacrolimus Versus Twice-Daily Immediate-Release Tacrolimus in Adult Hispanic Stable Kidney Transplant Recipients: Sub-Group Analysis from a Phase 3 Trial.
Journal: Annals of transplantation
Published: April 16, 2021
Kidney and pancreas transplant candidacy.
Journal: Current opinion in organ transplantation
Published: December 17, 2020
Should donors who have used marijuana be considered candidates for living kidney donation?
Journal: Clinical kidney journal
Published: July 25, 2018
Transplantation of hepatitis C virus (HCV) antibody positive, nucleic acid test negative donor kidneys to HCV negative patients frequently results in seroconversion but not HCV viremia.
Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Published: May 22, 2018
IgG Endopeptidase in Highly Sensitized Patients Undergoing Transplantation.
Journal: The New England journal of medicine
Published: August 03, 2017
Differences in pathologic features and graft outcomes in antibody-mediated rejection of renal allografts due to persistent/recurrent versus de novo donor-specific antibodies.
Journal: Kidney international
Published: July 05, 2016
Six-year outcomes in broadly HLA-sensitized living donor transplant recipients desensitized with intravenous immunoglobulin and rituximab.
Journal: Transplant international : official journal of the European Society for Organ Transplantation
Published: February 26, 2016
A Phase I/II Trial of the Interleukin-6 Receptor-Specific Humanized Monoclonal (Tocilizumab) + Intravenous Immunoglobulin in Difficult to Desensitize Patients.
Journal: Transplantation
Published: May 29, 2015
A phase I/II placebo-controlled trial of C1-inhibitor for prevention of antibody-mediated rejection in HLA sensitized patients.
Journal: Transplantation
Published: January 22, 2015
Last Updated: 09/26/2026